CDR-Life
Latest round
- Series A
Last raised
- Apr 2022
Total raised
- $76M
Investors
- 3
About CDR-Life
Based in Zürich, Switzerland, and founded in 2017 by Christian Leisner (CEO), CDR-Life Inc. is a biotechnology company that develops antibody technology, to target cancer-specific intracellular proteins. In April 2022, CDR-Life Inc. The firm has developed the unique M-gager® technology to generate MHC-specific antibody-based T cell engagers that target highly tumor-specific intracellular antigens with unparalleled specificity. The company’s dual-MHC binding molecule format based on antibody fragments has the capability of developing new immunotherapies with high tumor cell killing potency, longer duration of effect, and lower risk of immune-related adverse effects. The company’s few programs include CDR404 which is the most advanced program of the company for solid tumors, CDR101 is a trispecific next-generation BCMA targeting therapy for the treatment of relapsed/refractory multiple myeloma (RRMM), and many others.
Who invested in CDR-Life
3 investors across 1 round
See all investors in CDR-Life
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 13, 2022
Amount
$76M
Investors
Questions about CDR-Life
Who invested in CDR-Life?
CDR-Life has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CDR-Life raised?
CDR-Life has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did CDR-Life last raise money?
CDR-Life's most recent round on record is a Series A, in Apr 2022.
What does CDR-Life do?
Based in Zürich, Switzerland, and founded in 2017 by Christian Leisner (CEO), CDR-Life Inc.
Where is CDR-Life headquartered?
CDR-Life is headquartered in Zurich, Switzerland.
Which VCs invest in companies like CDR-Life?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at CDR-Life's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like CDR-Life? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.